chrisvoncsefalvay/vaers-outcomes huggingface dataset:
itchiness below the injection site/spreading; redness below the injection site; muscle pain on my neck; This spontaneous case was reported by a health care professional and describes the occurrence of NECK PAIN (muscle pain on my neck), VACCINATION SITE PRURITUS (itchiness below the injection site/spreading) and VACCINATION SITE ERYTHEMA (redness below the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy. Concomitant products included CALCIUM, FISH OIL and ASCORBIC ACID, BIOFLAVONOIDS NOS, HESPERIDIN, MALPIGHIA GLABRA, ROSA CANINA, RUTOSIDE (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS;HESPERIDIN;MALPIGHIA GLABRA;ROSA CANINA;RUTOSIDE]) for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 23-Feb-2021, the patient experienced NECK PAIN (muscle pain on my neck). On 03-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness below the injection site/spreading) and VACCINATION SITE ERYTHEMA (redness below the injection site).   The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency.   At the time of the report, NECK PAIN (muscle pain on my neck), VACCINATION SITE PRURITUS (itchiness below the injection site/spreading) and VACCINATION SITE ERYTHEMA (redness below the injection site) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: NNI updated for 1st dose of Vaccine
Tdap administered approximately 10:00 am at school clinic. As reported per school nurse, reddness and warmth were noted at the injection site almost immediately. Patient awoke the next morning with a fever of 102 degrees F and he complained of headache and an upset stomach. He was absent from school. The child returned to school in 48 hours with continued redness and swelling, but afebrile.
The consumer has not received the second dose.; Stroke; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (Stroke) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced CEREBROVASCULAR ACCIDENT (Stroke) (seriousness criterion medically significant). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (The consumer has not received the second dose.). At the time of the report, CEREBROVASCULAR ACCIDENT (Stroke) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (The consumer has not received the second dose.) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included unspecified High blood pressure medication. No treatment information was provided.  The reporter was unsure if the patient received the Moderna vaccine or the Pfizer vaccine  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
The day after my vaccine, I experienced muscle aches, chills, headache, and fatigue.  After 24 hours, I felt better. Now, a week after the vaccine, I have localized swelling around the injection site. It's also red and kind of firm to the touch. It's a little tender, but not very painful.
Vaccines given at 1600. At approx 1610 dad came and said pt had a white spot at vaccine site. Pt had 2 hives at site of injections (L thigh) between MMR and varicella. BENADRYL 2.5 ml given.
pt recv vax 17NOV97 & 7DEC97 pt devel a chickenpox like rash;
Rash on affected arm from shoulder to elbow (had blister), itching. No treatment. Rash started resolving 11/2/12, is still present but is getting better. Patient did take diphenhydramine.
Arm still sore almost two months after the injection/shot. Two shingles outbreaks since injection/shot. No prior history of shingles. Constant fatigue. Upper left chest pains. Increased bowel movements now result in two to three daily bowel movements instead of the once-daily pre-injection/shot.
This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6208, Expiration date was not reported), via an unspecified route of administration, in left arm on 23Mar2021 13:00 as first dose single for covid-19 immunisation. The patient medical history and concomitant medication were not reported. Patient did not receive prior Vaccinations (within 4 weeks). Patient states she received her first Pfizer Covid vaccine dose and then tested positive for Covid-19 on 29Mar2021. Patient asks, how long do I need to wait to get the second dose of the vaccine. The caller is calling about the Covid 19 vaccine. Patient received the Covid 19 vaccine, her first dose on 23Mar2021. Her husband and patient both got their first Covid 19 vaccines together. Both patient and her husband experienced their eye sockets just ached. They just did not feel well for a few days. Her husband is feeling better, he feels fine now. But now patient has a fever on 26Mar2021. Her temperature is a little over 100 F and her temperature usually runs low. Patient son-in-law took patient blood pressure today and it was 81/57 on 29Mar2021. She has been hydrating more. patient just feels generally awful. patient blood pressure has come back up. She is asking if she can still have symptoms this many days after receiving the Covid 19 vaccine. When probing for specific event details patient reports that patient and her husband eyes were achy immediately after receiving the Covid 19 vaccine. Patient has been taking Advil. Her husband thinks the Advil is masking her fever. patient also feels clammy on 26Mar2021. Today was the first time someone had taken her blood pressure. Patient started on Friday, feeling nauseated on an unspecified date in Mar2021. The patient underwent lab tests and procedures which included blood pressure: 81/57/low mmhg, temperature: runs low/little over 100 fahrenheit and covid-19: positive on 29Mar2021. The outcome of the events aching eye socket, fever, Clammy was not recovered, blood pressure abnormal was recovering and unknown for other events.
slight swelling; Red rash spreading in the right arm/starting to get dark; Red rash spreading in the right arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red rash spreading in the right arm/starting to get dark), VACCINATION SITE RASH (Red rash spreading in the right arm) and VACCINATION SITE SWELLING (slight swelling) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included MONTELUKAST and METOPROLOL for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red rash spreading in the right arm/starting to get dark) and VACCINATION SITE RASH (Red rash spreading in the right arm). On an unknown date, the patient experienced VACCINATION SITE SWELLING (slight swelling). At the time of the report, VACCINATION SITE ERYTHEMA (Red rash spreading in the right arm/starting to get dark), VACCINATION SITE RASH (Red rash spreading in the right arm) and VACCINATION SITE SWELLING (slight swelling) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.
Patient states that the vaccination was giving into the shoulder joint. It was causing him excessive pain and discomfort so he went to his physician. He was diagnosed with fluid in the shoulder joint. The physician recommended physical therapy which he is currently going through to treat the bursitis.
Felt completely normal at time of injection, and for several hours afterward. Began feeling pain and soreness at injection site around 11PM. Felt overall coldness and increased soreness at injection site when retiring to bed at 11:30PM. Experienced extremely vivid dreams prior to awaking at ~4AM with the need to urinate. Felt extremely hot, and somewhat concerning shortness of breath. Sat up in bed for 45-60 seconds prior to standing vertical. Felt normal when walking to bathroom and while urinating, no straining or abnormal effort required. Upon nearing completion of emptying bladder, ears began increasing intensity of ringing, followed immediately by cascading sensation of weakness. Realizing I was probably rapidly losing consciousness, I grabbed sink for support, in order to get as close to the ground as possible. Regained consciousness an unknown period of time later, though believed I was in bed. Upon noticing how cold my "bedsheets" were, I realized/remembered that I had lost consciousness. Felt completely weak and rested on floor for 30(?) minutes; attempts to move to a more veertical position were met with vague sensations of nausea. Eventually felt strong enough to drag myself to a nearby couch, where I slept on and off until 11:30AM, and gradually woke up to eat breakfast. I have experienced 1-2 episodes of syncope in my lifetime, and this instance aligns with how I felt at those times. Have never experienced micturition syncope at any point before, though.
COVID; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via agency through social media on 01-Dec-2020.  This case involves Adult patient who had covid (covid-19) (Corona virus dieases 2019) while the patient was treated with INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, past vaccination(s) were not provided.  Family history included patient two daughter had covid ,both got pneumonia.  On an unknown date in September-2020, the patient received suspect Influenza Vaccine produced by unknown manufacturer (lot number and expiry date not reported) at an unknown dose via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date in October-2020 (latency 1 month approximately) after the initiation of the suspect drug the patient had covid  (covid-19) .  It was reported that the patient believed that the flu shot helped, because her symptoms were not as bad as they could have been.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of the reporting , event outcome was unknown .  There will be no information available on batch number for this case .
This spontaneous case, initially received on 19-Aug-2016, was reported by a non health professional and concerns a male patient. Administration of company suspect drug(s): On an unknown date, the patient received Influenza Virus Vaccine (INN) for indication not reported (unknown strength/dosage/manufacturer). Dose regimen: Not reported, Route of administration: Not reported. Batch number: Not reported. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date, the patient experienced a bad reaction with a flu vaccine (outcome: not reported).
Patient received FLUZONE HD injection in left deltoid. After removing needle, the site started bleeding and within 1 minute, a large lump formed under the skin at injection site.
Ten to twenty minutes after receiving vaccination, employee experienced SOB and rapid HR. The first MMR she experienced this but it was a few days later. This time it was immediately.
Diarrhea; Sore throat; Nausea; feeling light-headed; adverse event after Moderna booster vaccine with mix and match after Pfizer; Chills; Headache; Muscle ache/Body ache; This spontaneous case was reported by a pharmacist and describes the occurrence of DIZZINESS (feeling light-headed), DIARRHOEA (Diarrhea), OROPHARYNGEAL PAIN (Sore throat), CHILLS (Chills) and HEADACHE (Headache) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Pfizer vaccine ((lot EN6208)) on 17-Mar-2021 and Pfizer vaccine ((lot EW0150)) on 08-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine and Pfizer vaccine. Concurrent medical conditions included Penicillin allergy, Allergy to allopathic drugs (sulfa, ACE-i), Hypertension since 2013 and Asthma since 1980. Concomitant products included LOSARTAN, AMLODIPINE and HCTZ for Hypertension.    On 31-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Oct-2021, the patient experienced CHILLS (Chills) and INTERCHANGE OF VACCINE PRODUCTS (adverse event after Moderna booster vaccine with mix and match after Pfizer). 31-Oct-2021, the patient experienced HEADACHE (Headache) and MYALGIA (Muscle ache/Body ache). 31-Oct-2021, the patient experienced CHILLS (Chills) and INTERCHANGE OF VACCINE PRODUCTS (adverse event after Moderna booster vaccine with mix and match after Pfizer). On 31-Oct-2021 at 3:30 AM, the patient experienced DIZZINESS (feeling light-headed). On 01-Nov-2021, the patient experienced DIARRHOEA (Diarrhea), OROPHARYNGEAL PAIN (Sore throat) and NAUSEA (Nausea). The patient was treated with NAPROXEN ongoing since an unknown date at an unspecified dose and frequency. On 31-Oct-2021, INTERCHANGE OF VACCINE PRODUCTS (adverse event after Moderna booster vaccine with mix and match after Pfizer) had resolved. At the time of the report, DIZZINESS (feeling light-headed), DIARRHOEA (Diarrhea), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Muscle ache/Body ache) and NAUSEA (Nausea) had resolved and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Birth control medication was taken orally.   Most recent FOLLOW-UP information incorporated above includes: On 04-Nov-2021: Reporter occupation and type updated, added medical history details, Updated event outcome
This case was reported by a pharmacist and described the occurrence of an injection site reaction in a pt who received DTAP (Infanrix) for prophylaxis. On an unspecified date in 2003, the pt received the fifth injection of Infanrix from either Lot # DTPA592B9 or DTPA592A9.  At an unknown time post-immunization, the pt experienced an injection site reaction characterized by "swelling spreading down the arm" and redness. The outcome of the events was unknown. The reporting pharmacist considered the events were probably related to vaccination with Infanrix. Comment: The reporter indicated that 15 to 17 children experienced these events following receipt of Infanrix Lots DTPA592B9 & DTPA592A9 for the fifth dose in the immunization series. However, they are not presently identifiable.
mom stated child cried for a long time & cry was high pitched & shrilling;pt couldn't get comfortable;legs red, hot & sore @ sites;warm but not high fever;t99.9ax; mom gave APAP & Ibuprofen;mom worried about similar rxn & requested DT;
Pt recv vax on 1/27/99; post vax pt exp worsening of sx:sweat, insomnia,fatigue, sore joints,chest tight,thinking abnorm, migraines,extremities swelling, blurring,painful intercourse, dizzy, constipation;new exp of faint,sore throat,numbnes
She got her vaccine, no problems, and then about 5-7 days later she started to get little blood spots on her skin, on the inside of her forearms and her upper chest.  That group would disappear and would get another group.  Then in late January of 2022 she started to get eye hemorrhages, which she is still continuing to have.  The blood spots under her arm skin and chest have died down some, but she gets the eye hemorrhages pretty constantly.  She went to her eye doctor and he gave her a thorough exam, could not find any reason in her eyes why it was happening, and was told to go to her PCP.  She had had a phone consultation and in April of 2022 she had thorough blood tests done which did not show anything there.  She was told that she had to wait out the hemorrhages on her eyes and there are activities that she does not do to make them worse.  She will not lift anything over a certain weights, and are a lot of things on the internet to do or not to do based on the hemorrhages.  She can just be sitting in a chair and when she gets up she can get a hemorrhage.  Sometimes the entire white of her eye is blood red.  Other than that there is nothing that can be done about it.  She gets them very frequently, has had 3 in a row over the past month or month and half.  She does have an eye drop that she just bought that she is going to use.  The eye doctors did give her some eye drops and she did have a reaction to those, but has bought a more natural kind.  This concerns as the information on line says that if you have more than 2 of eye hemorrhages in a year it is a concern, and she has had so many this year that she is worried.  She does have macular degeneration and has a very mild amount of it.  She is afraid to get any boosters due to this reaction.    She was trying to research on her own and did not find much about bleeding in eyes.
Narrative:  COVID infections following completion of COVID vaccine series 01/07/21 COVID vaccine dose #1 02/01/21 COVID vaccine dose #2 07/23/21 Pt reports sinus infection/head cold, congestion, worsening cough, low grade fever earlier in the week, temp 97.6; COVID POSITIVE 07/26/21 Pt reports cough, fatigue, fever, runny nose, shortness of breath, chest tightness; states he was seen at medical facility where CT scan, CXR, blood work, antibody infusion performed 07/27/21 Pt reports no symptoms and is improving 07/28/21 Clinically resolved
Gross blood in urine lasting 2 weeks. Trace amounts of blood still present. Metallic taste and smell.
nausea; fever; dizziness; weakness; fatigue; muscle pain; joint pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills) and NAUSEA (nausea) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event since an unknown date.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced FATIGUE (fatigue), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), PYREXIA (fever), DIZZINESS (dizziness) and ASTHENIA (weakness). On an unknown date, the patient experienced NAUSEA (nausea). At the time of the report, FATIGUE (fatigue), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), PYREXIA (fever), DIZZINESS (dizziness) and ASTHENIA (weakness) had not resolved.            Tylenol is the treatment received by the patient
Within a day I began to feel pressure in my chest and was feeling like I could not get enough air; Also, at times it was/is difficult to talk; Slight headache; lightheadedness; This is a spontaneous report from a contactable consumer or other non hcp female consumer (patient). A 67-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: EN6202), via an unspecified route of administration, administered in Arm Right on 04Mar2021 10:15 as 1st dose, single for covid-19 immunisation (Age at vaccination was 67 years).  Patient was pregnant at time of vaccination.  Medical history included autoimmune thyroiditis from an unknown date and unknown if ongoing, varicose vein from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported; liothyronine sodium (CYTOMEL) taken for an unspecified indication, start and stop date were not reported; loratadine (CLARITIN [LORATADINE]) taken for an unspecified indication, start and stop date were not reported; estradiol, estriol, estrone (TRIEST) taken for an unspecified indication, start and stop date were not reported; vitamin d3 (VITAMIN D3) taken for an unspecified indication, start and stop date were not reported. The patient previously took lamisil [terbinafine hydrochloride] and experienced drug hypersensitivity, tetanus vaccine and experienced drug hypersensitivity, betadine [povidone-iodine] and experienced drug hypersensitivity, gantrisine and experienced drug hypersensitivity.  The patient experienced within a day i began to feel pressure in my chest and was feeling like i could not get enough air, also, at times it was/is difficult to talk, slight headache, light headedness on 05Mar2021.  The patient underwent lab tests and procedures which included blood test: good   on Mar2021, chest x-ray: good   on Mar2021, oxygen saturation: good   on Mar2021.If other vaccine in four weeks was no.AE resulted in emergency room/department or urgent care. No, treatment was received. If covid prior vaccination was no. If covid tested post vaccination was unknown. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
swollen area rt thigh from knee to groin area;hot to touch, rash on stomach;went to ER given DPH & Keflex;
vials that were more than 30 days in refrigerator administered to patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vials that were more than 30 days in refrigerator administered to patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vials that were more than 30 days in refrigerator administered to patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vials that were more than 30 days in refrigerator administered to patients) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided by the reporter. No treatment medication were provided by the reporter.